adaura phase iii trial data: practice changing?
Published 4 years ago • 71 plays • Length 3:16Download video MP4
Download video MP3
Similar videos
-
5:08
ground-breaking data: phase 3 adaura trial
-
5:08
should adaura trial results change practice in nsclc?
-
11:58
asco 2023 - astrazeneca - positive results from adaura phase iii trial
-
4:06
clinical data from the phase iii prima trial
-
5:12
adaura trial: tagrisso & resectable egfr - leading developments & current questions in lung cancer
-
1:31:46
openflow: cell proliferation by flow cytometry ii
-
17:50
esophageal cancer awareness month: treatment advances and tools for maximizing tolerability
-
55:45
phase ii clinical trials
-
6:20
asco 2023 highlights on adjuvant osimertinib in resected egfr mutated nsclc: the adaura trial
-
1:18
expert discusses practice-changing data from katherine trial in breast cancer
-
1:45
phase iii data support frontline osimertinib in egfr-mutant lung cancers
-
0:58
adaura study demonstrates promising efficacy for osimertinib in egfr-mutant nsclc
-
5:54
key points from the adaura trial: osimertinib - targeted therapies in lung cancer 2023
-
2:34
dr. langer on practice-changing pacific data in stage iii nsclc
-
11:20
the oncology brothers discuss adaura trial findings
-
12:24
stephen liu md talks to us about the adaura trial
-
59:19
precision oncology in early-stage lung cancer, with adjuvant egfr-targeted therapy leading the way
-
2:06
adaura trial: osimertinib for early stage egfr nsclc - 2022 program: targeted therapies forum
-
4:25
adaura: osimertinib as adjuvant therapy in stage iii egfr nsclc
-
5:18
expert comment: the adaura results | lecia sequist
-
1:54
early survival data from phase iii trial for adjuvant temozolomide
-
5:18
jill feldman ma med discussing the adaura trial